O41 What is the best treatment strategy for Budd-Chiari patients with JAK2 mutation?
✍ Scribed by P. Reményi; Zs. Gerlei; T. Masszi
- Book ID
- 108424639
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 49 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0268-960X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The optimal treatment of Budd-Chiari syndrome (BCS) remains an open question. It is still a matter of controversial discussion whether venous decompression or liver transplantation is superior. To elucidate the role and prognosis of both surgical options in our own experience, a consecutive series o
We report the case of an elderly patient affected by Philadelphia positive Acute Lymphoblastic Leukaemia (Ph(+) ALL) who developed meningeal leukaemia during imatinib monotherapy, despite bone marrow molecular remission. Aggressive central nervous system (CNS)-directed therapy in combination with co